INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future
See why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.
-
Powering The Next Generation Of Drug Delivery Systems
Discover how pharmaceutical extrusion, including aseptic methods, enables advanced drug delivery systems, detailing the critical process controls required for success with complex and novel drug products.
-
What To Consider When Looking For A CDMO In Drug Substance Utilization
Optimize drug substance use during fill/finish. Learn how advanced line configurations and 100% non-destructive weight checks mitigate process drift, protect therapeutics, and prevent product loss.
-
CDMO Checklist To Choose The Right Aseptic Isolator
Selecting the right isolator for aseptic filling requires more than comparing features. Discover essential questions to ask and make informed decisions that align with your process and operational goals.
-
Effective Strategies To Minimize Product Loss During Fill Finish5/11/2026
Every drop of high-value biologic lost in fill finish is money left on the table. Learn practical strategies to protect your yield.
-
Product-Wet Integrity Testing: Risk-Based Strategies5/22/2026
When standard water‑based integrity testing falls short, product‑wet approaches can offer a more representative alternative. Learn how risk‑based strategies are used to establish reliable test limits.
-
From Complexity To Confidence: Supporting Tech Transfer With A Prefillable Syringe System6/2/2026
Discover how aligning packaging strategy with technology transfer requirements can accelerate timelines, control costs, and support successful injectable drug product manufacturing.
-
Agile Sterile Injectable Filling for Faster Market Entry9/21/2025
CMOs specializing in sterile injectable filling help pharmaceutical companies speed up product development and commercialization through flexible manufacturing, adaptability, and strong collaboration.
-
What Biotech Startups Need To Know About Sterile Fill Finish Services2/24/2026
Sterile fill–finish is a critical, tightly regulated stage for biotechs, demanding strong contamination control, smart CDMO selection, and awareness of capacity, scalability, and regulatory hurdles.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Through a science-led approach and extensive experience in product development, our team can support you with aseptic and terminally sterilized small volume liquids, as well as ocular and pulmonary delivery.
-
Available Immediately
Turnkey Contract Pharmaceutical Operation Available Immediately. Manufacturing OTC Sprays, Liquids, Creams, Aerosols, Gels, Inhalers, & More!
-
Discover how Cambrex can reliably develop and manufacture a broad spectrum of HPAPIs and compounds.
-
Closed RABS as a housing for aseptic processes, e.g., filling, loading, and unloading of freeze dryers. Product protection is achieved through a barrier (cRABS housing with gloves) between the operator and the product.
-
Dec‘s philosophy is to develop customer-specific modules and equipment. Starting with agreed project scope, intensive brainstorm sessions, strong design processes and (customer) reviews, the aim is to deliver an innovative filling solution. During the concept development, risk analysis is an important tool in the decision-making process.